Profile data is unavailable for this security.
About the company
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a China-based company principally engaged in the research, development, manufacturing and retail of Chinese herbal medicines, Chinese patent medicines, chemical raw materials and preparations, and nutritional health products. The Company operates its businesses through three segments. The Chinese Patent Medicine segment is mainly engaged in the research, development, manufacturing and sales of Chinese medicines, including Su Xiao Jiu Xin Pill, Jing Wan Hong Ruan Gao, An Gong Niu Huang Pill, Qing Gong Shou Tao Pill and other products. The Western Medicine segment is mainly engaged in the research, development, manufacturing and sales of Western medicines. The Others segment mainly includes economic information consulting services, house leasing and other businesses. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)5.37bn
- Net income in CNY3.58bn
- Incorporated1981
- Employees3.84k
- LocationTianjin Pharmaceutical Da Ren Tang Group Corp LtdNo. 17, Baidi Road, Nankai DistrictTIANJIN 300193ChinaCHN
- Phone+86 2 227020892
- Fax+86 2 227020892
- Websitehttps://www.jydrt.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 742.28m | -133.34m | 25.40bn | 910.00 | -- | 22.10 | -- | 34.22 | -0.5038 | -0.5038 | 2.80 | 4.34 | 0.2482 | 0.446 | 4.77 | 815,689.40 | -4.56 | -17.15 | -8.23 | -25.89 | 89.95 | 93.14 | -18.36 | -118.33 | 1.72 | -- | 0.4949 | -- | 37.91 | -- | 50.52 | -- | 44.66 | -- |
| Kangmei Pharmaceutical Co Ltd | 5.28bn | 16.64m | 26.69bn | 4.23k | 1,678.26 | 3.71 | -- | 5.06 | 0.0012 | 0.0012 | 0.3973 | 0.5197 | 0.3785 | 1.64 | 2.23 | 1,246,204.00 | 0.1368 | -21.82 | 0.2232 | -42.17 | 17.12 | -92.73 | 0.3614 | -108.18 | 0.7875 | -- | 0.0162 | -- | 6.47 | -14.63 | -91.64 | -- | -33.46 | -- |
| Xiamen Amoytop Biotech Co Ltd | 3.34bn | 939.58m | 28.11bn | 2.42k | 29.81 | 9.31 | -- | 8.41 | 2.31 | 2.31 | 8.22 | 7.40 | 1.03 | 0.8127 | 4.99 | 1,379,284.00 | 29.05 | 22.72 | 33.93 | 26.54 | 92.37 | 91.62 | 28.11 | 23.51 | 3.20 | -- | 0.0448 | 28.80 | 34.13 | 31.02 | 49.00 | 66.70 | 41.17 | 90.06 |
| Bluestar Adisseo Co | 17.09bn | 1.19bn | 30.80bn | 2.93k | 22.49 | 1.59 | -- | 1.80 | 0.4447 | 0.4447 | 6.37 | 6.31 | 0.7204 | 5.30 | 8.18 | 5,834,541.00 | 5.03 | 5.20 | 6.05 | 6.63 | 27.69 | 29.69 | 6.99 | 8.12 | 1.12 | 10.31 | 0.1377 | 30.01 | 17.83 | 6.88 | 2,208.66 | 3.95 | 5.53 | -7.02 |
| Humanwell Healthcare Group Co Ltd | 24.18bn | 1.43bn | 30.87bn | 17.65k | 21.63 | 1.63 | -- | 1.28 | 0.8741 | 0.8741 | 14.84 | 11.59 | 0.6519 | 3.63 | 2.48 | 1,369,715.00 | 5.00 | 6.40 | 8.73 | 12.55 | 44.53 | 43.83 | 7.67 | 9.90 | 1.40 | 362.14 | 0.2889 | 25.97 | 3.71 | 3.13 | -37.70 | 11.15 | 4.75 | 56.54 |
| Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd | 5.37bn | 3.58bn | 31.26bn | 3.84k | 10.03 | 3.99 | -- | 5.83 | 4.65 | 4.65 | 6.98 | 11.70 | 0.4758 | 1.35 | 3.16 | 1,399,130.00 | 31.64 | 11.74 | 45.06 | 16.76 | 64.27 | 42.04 | 66.50 | 14.81 | 2.33 | -- | 0.0056 | 54.04 | -11.14 | 0.8791 | 125.94 | 28.94 | -10.54 | 33.67 |
| Shanghai Junshi Biosciences Co Ltd | 2.48bn | -949.86m | 32.48bn | 2.67k | -- | 5.90 | -- | 13.08 | -0.96 | -0.96 | 2.51 | 6.05 | 0.2203 | 0.8436 | 5.48 | 963,148.80 | -9.45 | -17.61 | -12.31 | -22.00 | 81.59 | 68.46 | -42.92 | -84.56 | 1.43 | -23.04 | 0.3629 | -- | 29.67 | 20.24 | 43.90 | -- | -4.33 | -- |
| Beijing Tiantan Biological Products Corp | 6.42bn | 1.32bn | 32.63bn | 5.30k | 24.79 | 2.85 | -- | 5.08 | 0.6656 | 0.6656 | 3.25 | 5.80 | 0.4002 | 0.9382 | 11.21 | 1,212,453.00 | 11.25 | 11.93 | 16.06 | 16.79 | 45.65 | 50.69 | 28.10 | 29.69 | 3.08 | -- | 0.0152 | 16.24 | 16.44 | 12.94 | 39.58 | 20.45 | 15.19 | 23.56 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.37bn | 870.39m | 37.38bn | 995.00 | 43.14 | 6.32 | -- | 27.28 | 1.40 | 1.40 | 2.21 | 9.56 | 0.186 | 1.54 | 4.55 | 1,377,045.00 | 11.66 | 3.14 | 15.35 | 3.34 | 74.88 | 77.37 | 62.65 | 16.95 | 1.97 | -- | 0.00 | 12.57 | 17.70 | 0.2733 | 139.15 | 25.17 | 16.61 | -- |
Data as of Feb 11 2026. Currency figures normalised to Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 4.25m | 0.75% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.68m | 0.30% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.56m | 0.28% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.15m | 0.20% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 797.50k | 0.14% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 794.67k | 0.14% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 593.50k | 0.11% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 570.94k | 0.10% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 540.40k | 0.10% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 479.61k | 0.09% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
